In experimental models of stroke, EVs from MSCs with overexpressed microRNA 133b have improved functional recovery and neuroplasticity compared to rats treated with PBS or control MSCEvwt, possibly due to secondary release of EVs from astrocytes62 downregulating connective tissue growth factor (CTGF)63. The gene discussed is CCN2; the disease is stroke disorder.